Retinoblastoma Eye Cancer Treatment in India for Children: Globe Salvage, Costs & International Patient Guide
Retinoblastoma is the most common eye cancer in children, occurring almost exclusively in those under 5 years old. In high-income countries with advanced early detection programmes and modern treatment, over 95% of children survive and most retain at least one functional eye. In sub-Saharan Africa, late diagnosis — children presenting with orbital invasion or metastatic disease — remains common, and even where diagnosis is timely, access to intra-arterial chemotherapy (IAC) is essentially absent. India's paediatric ophthalmology centres offer the full spectrum of retinoblastoma treatment at a fraction of Western costs.
TL;DR: IAC for retinoblastoma costs USD 2,500–4,000 per cycle (3–6 cycles needed). Globe salvage rates are 85–95% for Group A–C. Full treatment packages start from USD 12,000. Early diagnosis is the single most important determinant of eye and vision preservation.
Understanding Retinoblastoma
Genetics and Hereditary Risk
Retinoblastoma arises from mutations in the RB1 tumour suppressor gene. Two forms exist:
Hereditary (40%): Germline RB1 mutation present in every cell. Affects both eyes (bilateral) in 75–80% of cases. Presents earlier, typically in the first year of life. Children of survivors have a 50% risk of passing the mutation. Siblings of affected children require ophthalmoscopy screening from birth.
Non-hereditary (60%): Somatic mutation in retinal cells only. Typically unilateral, presenting slightly later (average age 2 years).
The International Classification (IIRC Groups A–E)
| Group | Description | Globe Salvage with IAC |
|---|---|---|
| A | Small tumours away from fovea/disc | 95–100% |
| B | Larger tumours, subretinal fluid | 90–95% |
| C | Focal vitreous/subretinal seeds | 80–90% |
| D | Diffuse vitreous/subretinal seeds | 60–70% |
| E | Massive disease, neovascular glaucoma | 25–40% |
Group E eyes are typically enucleated as globe salvage rates are low and vision preservation is unlikely. Groups A through C are the primary targets for IAC globe-salvage approaches.
Diagnosis: What to Bring to India
The classic presentation of retinoblastoma is leukocoria — a white pupillary reflex visible in photographs when flash is used. The affected eye reflects white rather than red. This is often first noticed by parents in photos. Strabismus (squint) is another common presentation when tumour impairs vision.
If retinoblastoma is suspected, bring to India:
- Ophthalmology examination records
- Any imaging performed (orbital MRI is the standard imaging — bring the CD)
- Family history of retinoblastoma or eye conditions
Indian paediatric ophthalmologists will perform examination under anaesthesia (EUA) to accurately classify tumour extent before any treatment decision. This cannot be adequately done in a clinic without anaesthesia in young children.
Treatment Modalities at Indian Centres
Intra-Arterial Chemotherapy (IAC)
IAC is the leading globe-salvage technique for Groups B through D retinoblastoma. An interventional radiologist passes a microcatheter from the femoral artery (groin), through the internal carotid, and into the ophthalmic artery — the vessel supplying the eye. Chemotherapy (melphalan alone or in combination with topotecan or carboplatin) is infused directly into the arterial supply of the eye.
Advantages: Very high drug concentration in the tumour with minimal systemic exposure. Treats seeds (floating tumour cells in vitreous or subretinal space) that are difficult to reach with systemic drugs.
Sessions: 3–6 monthly sessions required. Each session is 1–2 hours under general anaesthesia (child is anaesthetised).
Costs in India: USD 2,500–4,000 per session. Complete IAC course: USD 10,000–20,000.
Results: In India's leading centres (LV Prasad Eye Institute, Sankara Nethralaya, Aravind Eye Hospitals), Group C globe salvage rates of 80–90% are consistently reported.
Systemic Chemotherapy (IV Chemo)
For bilateral retinoblastoma, high-risk pathological features post-enucleation, or as combined therapy with IAC, intravenous chemotherapy (carboplatin, vincristine, etoposide) is used. Courses of 6 cycles are standard.
Costs in India: USD 500–1,000 per cycle. Six cycles: USD 3,000–6,000.
Focal Consolidation (Laser and Cryotherapy)
After IAC or systemic chemotherapy has reduced tumour size, residual tumour is treated with focal consolidation: laser photocoagulation, transpupillary thermotherapy (TTT), or cryotherapy. These office-procedure-level treatments cost USD 200–600 per session and are performed under sedation.
Enucleation
When globe salvage is not appropriate (Group E, failed IAC, blind painful eye), enucleation removes the affected eye. Histopathological analysis identifies high-risk features requiring adjuvant chemotherapy. A prosthetic eye is fitted subsequently.
Costs in India: Enucleation USD 3,000–5,000. Ocular prosthesis fitting USD 500–1,500.
Cost Summary
| Treatment | India (USD) | USA (USD) | UK (GBP) |
|---|---|---|---|
| IAC (per cycle) | 2,500–4,000 | 15,000–25,000 | 10,000–18,000 |
| Full IAC course (6 cycles) | 15,000–24,000 | 90,000–150,000 | 60,000–100,000 |
| IV chemotherapy (6 cycles) | 3,000–6,000 | 30,000–60,000 | 20,000–40,000 |
| Enucleation + prosthesis | 3,500–6,500 | 20,000–40,000 | 15,000–30,000 |
Genetic Testing and Counselling
Given the hereditary nature of retinoblastoma, RB1 germline testing is recommended for all bilateral cases, unilateral cases with family history, and young unilateral patients. Indian genetics laboratories offer RB1 molecular testing for USD 300–600. Genetic counselling for the family is included at specialist centres.
Siblings of affected children require ophthalmoscopy under anaesthesia from birth through age 4 if the affected child carries a germline mutation. Arodya can arrange sibling screening during the same India visit.
The Emotional Journey
Retinoblastoma diagnosis in a young child is devastating for families. India's paediatric ophthalmology centres understand this. Child life specialists, family accommodation within or near the hospital, and support for accompanying parents are standard at leading centres. The Arodya patient community also connects families going through retinoblastoma treatment — the shared experience of other African parents who have been through the journey is invaluable.
For families facing paediatric cancer more broadly, our comprehensive childhood cancer treatment guide covers the full range of conditions treated at Indian paediatric oncology centres. For bone marrow transplant needs in high-risk retinoblastoma, see our bone marrow transplant guide.
Time is critical with retinoblastoma — delayed diagnosis increases tumour group, reduces globe salvage chances, and risks metastatic spread. Contact Arodya immediately if your child has a white pupil reflex or any concern about their eyes.
